Patient Receptiveness to Using Virtual Reality
Status: | Recruiting |
---|---|
Conditions: | Anxiety, Anxiety, Chronic Pain |
Therapuetic Areas: | Musculoskeletal, Psychiatry / Psychology |
Healthy: | No |
Age Range: | 20 - 80 |
Updated: | 5/20/2018 |
Start Date: | April 16, 2018 |
End Date: | October 12, 2018 |
Contact: | Paul M Arnstein, PhD |
Email: | pmarnstein@mgh.harvard.edu |
Phone: | (617)724-8517 |
Patient Receptiveness to Using Virtual Reality as a Distractor From Pain
This study will evaluate the acceptability, use, and general effect that exposure to virtual
reality has on hospitalized patients reporting at least one discomfort including recent or
current moderate-severe pain.
reality has on hospitalized patients reporting at least one discomfort including recent or
current moderate-severe pain.
Patients with moderate-severe pain will be approached with approval of nursing staff and
front line nurse manager who determine their appropriateness for a trial of virtual reality
(VR) exposure for up to 30 minutes. The trial and use of VR will be explained after meeting
the inclusion criteria and they will be asked about their level of interest in trying the VR
headset. If interested, the subject will indicate their verbal consent to proceed with the VR
trial. They will be asked about any baseline discomforts of pain, anxiety/stress or other
discomfort; which will be rated on a 0-10 numeric (visual analog) scale. A baseline heart
rate will be recorded in beats per minute. The headset will be applied and adjusted for
comfort, then the app will be started along with a timer to track the duration of their use
up to a maximum of 30 minutes. When the Headset is removed, the duration of use will be
noted. The change in post-exposure heart rate (in beats per minute) and discomforts of pain,
anxiety/stress or other discomforts (subtracting baseline from 5 minute post-exposure data)
will be recorded. Subjects will be asked about the ease of use, whether or not they would use
VR again, and for any other comments they would like to express. The headset will be
disinfected between patient use.
front line nurse manager who determine their appropriateness for a trial of virtual reality
(VR) exposure for up to 30 minutes. The trial and use of VR will be explained after meeting
the inclusion criteria and they will be asked about their level of interest in trying the VR
headset. If interested, the subject will indicate their verbal consent to proceed with the VR
trial. They will be asked about any baseline discomforts of pain, anxiety/stress or other
discomfort; which will be rated on a 0-10 numeric (visual analog) scale. A baseline heart
rate will be recorded in beats per minute. The headset will be applied and adjusted for
comfort, then the app will be started along with a timer to track the duration of their use
up to a maximum of 30 minutes. When the Headset is removed, the duration of use will be
noted. The change in post-exposure heart rate (in beats per minute) and discomforts of pain,
anxiety/stress or other discomforts (subtracting baseline from 5 minute post-exposure data)
will be recorded. Subjects will be asked about the ease of use, whether or not they would use
VR again, and for any other comments they would like to express. The headset will be
disinfected between patient use.
Inclusion Criteria:
- English-speaking
- Inpatients on a general care unit
- Current or recorded moderate to severe pain in past 24 hours
Exclusion Criteria:
- Receiving palliative/end of life care;
- Admitted for treatment of psychiatric or mental health disorder
- History of seizure or stroke
- Legally blind or deaf
- Moderate or severe cognitive impairment
- Head wounds or bandages
- On isolation precautions.
We found this trial at
1
site
185 Cambridge Street
Boston, Massachusetts 02114
Boston, Massachusetts 02114
617-724-5200
Phone: 617-724-8517
Click here to add this to my saved trials